Mar 4, 2026 05:46PM
Mar 3, 2026 05:00PM
Feb 25, 2026 07:00AM
Feb 25, 2026 07:00AM
Feb 24, 2026 04:05PM
Feb 4, 2026 09:05AM
Feb 4, 2026 09:05AM Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program
Dec 8, 2025 09:05AM
Nov 4, 2025 05:00PM
Oct 28, 2025 04:05PM
Oct 20, 2025 09:05AM
Oct 20, 2025 09:05AM
Oct 20, 2025 09:01AM
Oct 20, 2025 09:00AM RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
Oct 13, 2025 09:05AM
Oct 1, 2025 09:06AM
Oct 1, 2025 09:05AM
Sep 29, 2025 09:05AM
Sep 8, 2025 07:00AM
Sep 8, 2025 07:00AM
Aug 5, 2025 04:05PM Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date
Aug 4, 2025 09:05AM
Aug 4, 2025 09:05AM
Jul 29, 2025 04:05PM
Jun 23, 2025 09:06AM
Jun 23, 2025 09:05AM
May 27, 2025 04:09PM
May 27, 2025 04:05PM NEW STUDY FINDS CALDOLOR® SAFE AND EFFECTIVE FOR OPIOID-SPARING PAIN MANAGEMENT IN OLDER ADULTS
May 13, 2025 04:05PM
May 6, 2025 04:05PM
Apr 29, 2025 04:05PM
Mar 19, 2025 04:05PM
Mar 4, 2025 04:05PM
Feb 25, 2025 04:05PM
Feb 18, 2025 07:30AM VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA
Feb 4, 2025 07:30AM
Feb 4, 2025 07:30AM
Dec 10, 2024 08:24AM
Dec 9, 2024 04:05PM
Nov 7, 2024 04:05PM
Nov 6, 2024 05:22PM
Nov 6, 2024 05:21PM CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
Nov 5, 2024 04:05PM
Oct 31, 2024 04:05PM
Aug 6, 2024 04:05PM
Jul 30, 2024 04:05PM
May 7, 2024 04:05PM
Apr 30, 2024 04:05PM
Apr 2, 2024 04:05PM NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
Mar 5, 2024 04:05PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All